Irene Cheung is a family nurse practitioner whose clinical experience includes primary care, occupational health, and telehealth, and is the clinical lead for Labcorp OnDemand.

Notable Roles

• Labcorp - Clinical Specialist on the Clinical and Digital Solutions Team; Clinical lead for OnDemand (Labcorp's DTC platform) 
• Hims & Hers - Family Nurse Practitioner 
• Abbott - Occupational Health Nurse Practitioner 
• CVS Health - Family Nurse Practitioner

Dr. Nicola Sing is a board-certified family medicine physician focused on evidence-based clinical content development for Labcorp's portfolio of IT solutions.

Gary M. Stuhlmiller, PhD, serves as a technical director in the division of DNA identity testing at Labcorp. He joined Labcorp following 11 years on the faculty in the Department of Surgery at Duke University Medical Center, where he was technical director of the Melanoma Immunobiology Laboratory. Dr. Stuhlmiller holds a BS in Microbiology from Cornell University and a PhD in Immunology from Duke University. Dr.

Dr. Minghui Li earned his PhD in cellular and molecular biology from the University of Nevada, Reno, and his master’s degree in clinical laboratory science from Augusta University, Augusta, GA. Dr Li joined the DNA Identification laboratory after completing his HLA lab director- in-training at Virginia Commonwealth University’s HLA laboratory. His current responsibilities include human leukocyte antigen (HLA) testing for disease associations, pharmacogenomics and histocompatibility support for transplant centers and bone marrow registries. Dr.

Dr. Vera Lattier received her PhD in molecular and cellular biology from Oregon State University, Corvallis, and her master’s degree in pathology from National Taiwan University, Taipei, Taiwan. She completed post-doctoral training at the National Cancer Institute, National Institute of Health, Bethesda, MD. Before joining Labcorp, she worked as a research and development scientist in drug discovery and assay development. She has discovered several genetic biomarkers associated to disease prognosis and published numerous scientific articles in international journals.

Dr. Megan Shaffer completed her PhD in microbiology and immunology at Louisiana State University Health Sciences Center, Shreveport, and continued post-doctoral training at Louisiana State University Health Sciences Center, New Orleans. Dr. Shaffer holds a certificate of qualification from the New York State Department of Health to act as a laboratory director in the categories of histocompatibility, transplant monitoring, forensic identity and parentage/identity testing. She is board certified as an associate of the American College of Histocompatibility and Immunogenetics (ACHI).